Invenire Partners’s CryoPort CYRX Stock Holding History

Invenire Partners’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-45,283	Closed	-$1.4M	–	29
2022 Q2	$1.4M	Buy	+45,283	New	+$1.2M	1.86%	25

Other funds holding CYRX

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Invenire Partners's CYRX Position: Q3 2022 in Review

Invenire Partners sold out of CryoPort (CYRX) in Q3 2022, closing a stake of 45,283 shares — an estimated $1.4M sold.

Invenire Partners first reported a position in CYRX in Q2 2022 and held it in 1 quarter. The position peaked at $1.4M in Q2 2022. 194 funds tracked by Wall St. Rank hold CYRX as of Q3 2022.

Invenire Partners reported no remaining CryoPort position as of Q3 2022 after selling out during the quarter.
Invenire Partners sold 45,283 CryoPort shares in Q3 2022, an estimated $1.4M.
Invenire Partners first reported a position in CryoPort in Q2 2022 and held it in 1 quarter.
Invenire Partners's CryoPort position peaked at $1.4M in Q2 2022.
194 funds tracked by Wall St. Rank held CryoPort as of Q3 2022.

Based on Invenire Partners's 13F filing for Q3 2022, filed 14 Nov 2022.